Inventaire - your friends and communities are your best library

Antidiabetic therapies affect risk of pancreatic cancer

author

Marina Konopleva

published in: Gastroenterology

date of publication: 2009-04-16

language: English

main subject: pancreatic cancer

Cites articles 31

Date

Title

Authors

2008-04-02

Accuracy of patients' reports of comorbid disease and their association with mortality in ESRD.

Sharon Stein Merkin, Laura C Plantinga, Nancy E Fink
2008-01-18

Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus

William Bamlet, Gloria M Petersen
2008-03-14

Targeting AMPK: a new therapeutic opportunity in breast cancer
2008-03-07

LKB1 and AMPK in cell polarity and division
2008

Cancer statistics, 2008

Michael Thun
2008-01-21

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

Sophie Giorgetti-Peraldi, Patrick Auberger, Jean-François Tanti, Frédéric Bost
2008-01-01

Standards of medical care in diabetes--2008.

American Diabetes Association
2007-10-26

Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer

Mariza de Andrade, Kari G Rabe, Gloria M Petersen, Cynthia L. Leibson, Jeanine E. Ransom
2007-08-31

Risk factors for pancreatic cancer: case-control study

Jean-Nicolas Vauthey, James Lewis Abbruzzese, Donghui Li, Lamiece Hassan, Melissa L Bondy, Renato Lenzi
2007-07-01

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

Benoit Viollet, Craig B. Thompson
2007-05-01

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

Edward Giovannucci
2006-10-23

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

Nahum Sonenberg, Ryan Dowling
2006-08-01

Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
2006-02-01

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
2005-06-06

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
2005-04-22

Metformin and reduced risk of cancer in diabetic patients

Dario Alessi
2005-06-01

Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice
2004-12-13

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer
2004-08

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Eugenia Calle
2003-01-01

Insulin and longevity: antidiabetic biguanides as geroprotectors

Vladimir N. Anisimov
2003-01-01

Metformin: new understandings, new uses

Silvio E Inzucchi
2003-05-01

An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress
2002-07-02

Metformin: An Update
2002-05-06

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways

David Carling
2001-04-01

Prevention of pancreatic cancer induction in hamsters by metformin
2000-10-01

Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression
1999-08-01

Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer

Debra T. Silverman, Robert N. Hoover
1995-02

Insulin-like growth factors and their binding proteins: biological actions
1995-05-01

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
1988-07-01

The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data
1978-01-01

Inhibition of DMBA-induced carcinogenesis by phenformin in the mammary gland of rats

Article - wd:Q34976430

Welcome to Inventaire

the library of your friends and communities

learn more